Supervised physical activity in patients with symptomatic peripheral arterial disease: protocol for a randomized clinical trial (ARTPERfit Study)

M. ALZAMORA, R. FORES, N. SERRA, E. MARTINEZ, G. PERA, G. SEDA, J. PALENCIA, M. GOMIS, A. TEBAR, M. VALVERDE, M. GARNACHO and P. TORAN
BMJ Open. 2022 Apr 1; . doi:10.1136/bmjopen-2021-054352; PMID:35477870

• Any: 01/04/2022
• FI: 2.9
• Article

TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population

A. MARTINEZ-ESCUDE, G. PERA, A. COSTA-GARRIDO, L. RODRIGUEZ, I. ARTEAGA, C. EXPOSITO-MARTINEZ, P. TORAN-MONSERRAT and L. CABALLERIA
Journal of Clinical Medicine. 2021 Jul 1; . doi:10.3390/jcm10132907; PMID:34209831

• Any: 01/07/2021
• FI: 4.964
• Article

Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects

A. MARTINEZ-ESCUDE, G. PERA, L. RODRIGUEZ, I. ARTEAGA, C. EXPOSITO-MARTINEZ, P. TORAN-MONSERRAT and L. CABALLERIA
Journal of Clinical Medicine. 2021 Apr 1; . doi:10.3390/jcm10071350; PMID:33805893

• Any: 01/04/2021
• FI: 4.964
• Article

Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.

Arteaga I, Chacón C, Martínez-Escudé A, Rojano IR, Diez-Fadrique G, Carmona-Cervelló M and Torán-Monserrat P
Diagnostics. 2025 Jan 27; . doi:10.3390/diagnostics15030299; PMID:39941229

• Any: 27/01/2025
• FI: 3
• Article

Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants

K. BECH, J. PUSTJENS, R. DE KNEGT, G. PERA, L. VAN KLEEF, H. SCHNEFELD, P. ANDERSEN, J. HANSEN, K. LINDVIG, R. NADAL, M. CAROL, A. SORIA, E. POSE, A. JUANOLA, A. ARSLANOW, N. FABRELLAS, M. SERRA, I. GRGUREVIC, L. CABALLERIA, S. PIANO, M. REICHERT, R. MORILLAS, J. PERICÀS, J. SCHATTENBERG, E. TSOCHATZIS, N. GUHA, P. TORÁN, C. FOURNIER-POIZAT, A. LLORCA, L. CASTERA, F. LAMMERT, I. GRAUPERA, A. KRAG, W. BROUWER, P. GINÈS and M. THIELE
JOURNAL OF HEPATOLOGY. 2024 Jun 1;

• Any: 01/06/2024
• FI: 26.8
• Article